Ertugliflozin

Таблетки, покрытые пленочной оболочкой By prescription

Hypoglycemic agent, inhibitor of sodium-dependent glucose transporter type 2 (NGLT2)

Ertugliflozin

Indications

The drug Ertugliflozin is used to treat adult patients 18 years and older with insufficiently controlled type 2 diabetes mellitus in addition to diet and exercise:

  • as monotherapy when metformin is not indicated due to intolerance or contraindications;
  • as a combination therapy with metformin, sulfonylureas, dipeptidyl peptidase 4 inhibitors (including in combination with metformin) and insulin preparations in the absence of adequate glycemic control on this therapy.

Contraindications

Do not take Ertugliflozin if you have:

  • allergy to ertugliflozin or any other components of the drug.

Usage

Your doctor will select the dose of Ertugliflozin for you. The recommended starting dose of Ertugliflozin is 5 mg once a day in the morning, regardless of food intake. Your doctor may reduce or increase your dose of Ertugliflozin, depending on your condition and how you will respond to treatment. The dose can be increased to 15 mg once a day. The drug Ertugliflozin can be prescribed to you as a single drug or in combination with other drugs that control blood sugar levels.

Download full instruction

Report undesirable reaction

If you have information about undesirable reaction after taking the drug

Hotline +7 (495) 984-28-47

Report

Have questions? Contact Us

Has contraindications. Needs specialist overview.

Please read our privacy policy

The present personal data processing policy is drawn up in accordance with the requirements of the Federal Law of July 27, 2006. No. 152-FЗ “On Personal Data” and determines the procedure for processing personal data and measures to ensure the security of personal data of Mir-Pharm LLC (hereinafter referred to as the Operator).

The operator sets as his most important goal and condition for the implementation of his activities the respect for the rights and freedoms of man and citizen in the processing of his personal data, including the protection of the rights to privacy, personal and family confidentiality.

The Operator's policy regarding the processing of personal data (hereinafter - the Policy) applies to all information that the Operator can receive about visitors of the website https://mirpharm.ru.

The user can get any clarification on issues of interest regarding the processing of his personal data by contacting the Operator via e-mail info@mirpharm.ru.

The current version of the Policy is located in free access on the Internet at https://mirpharm.ru/policy.

This document will reflect any changes in the policy of processing personal data by the Operator. The policy is valid indefinitely until it is replaced with a new version.